Abstract:Pancreatic cancer is unresectable in over 80 % of patients owing to difficulty in early diagnosis. Chemotherapy is the most frequently adopted therapy for advanced pancreatic cancer. The development of drug resistance to gemcitabine (GEM), which is always used in standard chemotherapy, often results in therapeutic failure. However, the molecular mechanisms underlying the gemcitabine resistance remain unclear. Therefore, we sought to explore the microRNA-mRNA network that is associated with the development of gemcitabine resistance and to identify molecular targets for overcoming the gemcitabine resistance. By exposing SW1990 pancreatic cancer cells to long-term gemcitabine with increasing concentrations, we established a gemcitabine-resistant cell line (SW1990/GEM) with a high IC50 (the concentration needed for 50 % growth inhibition, 847.23 μM). The mRNA and microRNA expression profiles of SW1990 cells and SW1990/GEM cells were determined using RNA-seq analysis. By comparing the results in control SW1990 cells, 507 upregulated genes and 550 downregulated genes in SW1990/GEM cells were identified as differentially expressed genes correlated with gemcitabine sensitivity. Gene ontology (GO) analysis showed that the differentially expressed genes were related to diverse biological processes. The upregulated genes were mainly associated with drug response and apoptosis, and the downregulated genes were correlated with cell cycle progression and RNA splicing. Concurrently, the differentially expressed microRNAs, which are the important player in drug resistance development, were also examined in SW1990/GEM cells, and 56 differential microRNAs were identified. Additionally, the expression profiles of selected genes and microRNAs were confirmed by using Q-PCR assays. Furthermore, combining the differentially expressed microRNAs and mRNAs as well as the predicted targets for these microRNAs, a core microRNA-mRNA regulatory network was constructed, which included hub microRNAs, such as hsa-miR-643, hsa-miR-4644, hsa-miR-4650-5p, hsa-miR-4455, hsa-miR-1261, and hsa-miR-3676. The predicted targets of these hub microRNAs in the microRNA-mRNA network were also observed in the identified differential genes. As a result, a differential gene and microRNA expression pattern was constructed in gemcitabine-resistant pancreatic cancer cells. Therefore, these data may be useful for the detection and treatment of drug resistance in pancreatic cancer patients, and the microRNA-mRNA network-based analysis is expected to be more effective and provides deep insights into the molecular mechanism of drug resistance.

Inducement's Impacts on Establishment of Multi-Drug-resistant Cell Line A549/Gem

Emodin Sensitizes the Gemcitabine-Resistant Cell Line Bxpc-3/Gem to Gemcitabine Via Downregulation of NF-κB and Its Regulated Targets.

Establishment and Characterization of a HER2-Positive Cell Line Derived from the Pleural Effusion of a Drug-Resistant Breast Cancer Patient

Oridonin Overcomes the Gemcitabine Resistant PANC-1/Gem Cells by Regulating GST Pi and LRP/1 ERK/JNK Signalling

Identification of chemoresistance‐related mRNAs based on gemcitabine‐resistant pancreatic cancer cell lines

[Mechanisms of the Drug Resistance of a 2', 2-Difluorodeoxycytide (Gemcitabine)-Resistant Variant of the Human Lung Adenocarcinoma Cell Line].

Development and Characterization of a Gemcitabine-resistant Variant of Human Lung Adenocarcinoma Cell Line A549

Establishment of a Multidrug-resistance Cell Lines A549/CDDP from Human Lung Adenocarecinoma Cells

Construction of Multidrug Resistant Cell Line BxPC-3/ADM of Pancreatic Cancer and Initial Investigation of Its Resistance Mechanism

DEVELOPMENT OF A K562 MULTIDRUG-RESISTANT CELL LINE AND STUDY ON PROTEINS WITH ALTERED EXPRESSION

Establishment of a docetaxel-induced human breast carcinoma drug-resistant cell line BT549/docetaxel and the mRNA expression of adenosine triphosphate binding cassette transporter G2, adenosine triphosphate binding cassette subfamily B member 1, multidrug

CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stroma.

[Multidrug Resistant Gene MDR1 Contributes to Development of Imatinib-Resistance in Ph (+) Acute Lymphoblastic Leukemia Cell Line SUP-BS15RI].

Time and concentration dependency of P-gp, MRP1 and MRP5 induction in response to gemcitabine uptake in Capan-2 pancreatic cancer cells

Establishment and biological characteristics of Taxol-induced drug resistant human lung adenocarcinoma cell line

MiR-17- 5p/RRM2 regulated gemcitabine resistance in lung cancer A549 cells

Establishment and Characterization of Multidrug-Resistant Gastric Cancer Cell Lines

Expression of XIAP in Pancreatic Carcinoma Cell Line BxPC-3 Induced by Gemcitabine

Gemcitabine Resistance in Breast Cancer Cells Regulated by PI3K/AKT-mediated Cellular Proliferation Exerts Negative Feedback Via the MEK/MAPK and Mtor Pathways

Identifying Microrna-Mrna Regulatory Network in Gemcitabine-Resistant Cells Derived from Human Pancreatic Cancer Cells